Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
36,559,637
-
Share change
-
-1,342,388
-
Total reported value
-
$68,366,000
-
Put/Call ratio
-
10%
-
Price per share
-
$1.87
-
Number of holders
-
64
-
Value change
-
-$5,960,260
-
Number of buys
-
25
-
Number of sells
-
40
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q2 2022
As of 30 Jun 2022,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,559,637 shares.
The largest 10 holders included
BVF INC/IL, Soleus Capital Management, L.P., Aquilo Capital Management, LLC, Lynx1 Capital Management LP, MARSHALL WACE, LLP, GREAT POINT PARTNERS LLC, CITADEL ADVISORS LLC, BlackRock Inc., Assenagon Asset Management S.A., and MORGAN STANLEY.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.